Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
Dalton
A
A
D001315:Australia; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017277:Drug Approval / Q000191:economics* / Q000379:methods; D004345:Drug Industry / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence / Q000592:standards; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence / Q000592:standards*; D009313:National Health Programs / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D016896:Treatment Outcome